We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current TBIO market cap is 5.74M. The company's latest EPS is USD -27.6061 and P/E is -0.12.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.56M | 6.98M | 3.44M | 299k | 1.57M |
| Operating Income | -10.12M | -17.48M | -8.52M | -10.76M | -5.48M |
| Net Income | -11.2M | -18.27M | -9.22M | -13.18M | -7.26M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.81M | 6.58M | 11.04M | 27.44M | 27.51M |
| Operating Income | -6.98M | -16.36M | -35.37M | -46.49M | -46.54M |
| Net Income | -8.3M | -18.01M | -38.96M | -48.47M | -49.02M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 105.03M | 70.41M | 63.33M | 52.73M | 24.74M |
| Total Liabilities | 58.54M | 40.87M | 41.68M | 42.78M | 20.86M |
| Total Equity | 17.77M | 238k | -8.24M | -20.54M | -27.22M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 38.76M | 26.86M | 116.26M | 81.36M | 70.41M |
| Total Liabilities | 7.35M | 13.41M | 25.47M | 34.8M | 40.87M |
| Total Equity | -7.5M | -25.46M | 90.78M | 46.57M | 238k |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.36M | -34.67M | -3.24M | -8.58M | -15.54M |
| Investing | -12.24M | -5.74M | 12.25M | 13.38M | 17.82M |
| Financing | 26.59M | 11.57M | -27k | -34k | -202k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.39M | -15.38M | -36.7M | -38.72M | -34.67M |
| Investing | -79k | -204k | -15.04M | -18.01M | -5.74M |
| Financing | 35.11M | -96k | 121.08M | 4.51M | 11.57M |
| Market Cap | 5.74M |
| Price to Earnings Ratio | -0.12 |
| Price to Sales Ratio | 0.21 |
| Price to Cash Ratio | 3.65 |
| Price to Book Ratio | 0.19 |
| Dividend Yield | - |
| Shares Outstanding | 1.78M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -55.91% |
| 52 Week High | 15.462 |
| 52 Week Low | 1.27 |
| Spread (Intraday) | 0.2 (5.97%) |
| Company Name | Telesis Bio Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.codexdna.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
